ConductScience.org, home

Paper20520719

Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Susa M and 8 others. PLoS One, 2010. Cited by 123 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. Papers, record 20520719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20520719

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
PubMed
Journal
PLoS One
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
3.39
iCite
Revised in PubMed
2022-03-18
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Susa MMichiro
2Iyer AKArun K
3Ryu KKeinosuke
4Choy EEdwin
5Hornicek FJFrancis J
6Mankin HHenry
7Milane LLara
8Amiji MMMansoor M
9Duan ZZhenfeng

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
Drug Resistance, NeoplasmMajor topic
Gene Transfer TechniquesMajor topic
NanoparticlesMajor topic
OsteosarcomaMajor topic
RNA, Small InterferingMajor topic
ATP Binding Cassette Transporter, Subfamily B
Animals
Blotting, Western
Cell Death
Cell Line, Tumor
Dextrans
Doxorubicin
Fluoresceins
Green Fluorescent Proteins
Humans
Intracellular Space
Lipids
Subcellular Fractions

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA119617NCI NIH HHSUnited StatesR01CA119617PubMed and NIH
R01-CA119617NCI NIH HHSUnited StatesR01CA119617PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116831079Chemotherapy resistance in osteosarcoma: current challenges and future directions.Expert Rev Anticancer Ther2006https://conductscience.org/library/papers/16831079PubMed
27912530Taxol: mechanisms of action and resistance.J Natl Cancer Inst Monogr1993https://conductscience.org/library/papers/7912530PubMed
37879670Multidrug resistance in the laboratory and clinic.Adv Clin Chem1994https://conductscience.org/library/papers/7879670PubMed
41816768Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].Eur J Cancer1991https://conductscience.org/library/papers/1816768PubMed
519917123Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.BMC Cancer2009https://conductscience.org/library/papers/19917123PubMed
69408960Pharmacologic approaches to reversing multidrug resistance.Semin Hematol1997https://conductscience.org/library/papers/9408960PubMed
72946403A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer Res1986https://conductscience.org/library/papers/2946403PubMed
89627221Cytometric study of intracellular P-gp expression and reversal of drug resistance.Cytometry1998https://conductscience.org/library/papers/9627221PubMed
91671173Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1671173PubMed
1016952261Nonfouling characteristics of dextran-containing surfaces.Langmuir2006https://conductscience.org/library/papers/16952261PubMed
1117096323Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.Int J Cancer2007https://conductscience.org/library/papers/17096323PubMed
1215514371
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
J Clin Oncol2004https://conductscience.org/library/papers/15514371PubMed
132565763Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA.Cancer Res1989https://conductscience.org/library/papers/2565763PubMed
1417393074Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.Pharm Res2007https://conductscience.org/library/papers/17393074PubMed
1511033070Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.Eur J Pharm Sci2000https://conductscience.org/library/papers/11033070PubMed
161968358Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.Cancer Res1990https://conductscience.org/library/papers/1968358PubMed
1710728603Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.Int J Cancer2000https://conductscience.org/library/papers/10728603PubMed
1813650640Tissue sulfhydryl groups.Arch Biochem Biophys1959https://conductscience.org/library/papers/13650640PubMed
1916935749Exploiting the enhanced permeability and retention effect for tumor targeting.Drug Discov Today2006https://conductscience.org/library/papers/16935749PubMed
208102521Biochemistry of multidrug resistance mediated by the multidrug transporter.Annu Rev Biochem1993https://conductscience.org/library/papers/8102521PubMed

See all 44 referencesDownload CSV of references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
42388536Enhanced endosomal escape for nanoparticle-enabled co-delivery of doxorubicin and siRNA to overcome multidrug resistance.Mater Today Adv2026https://conductscience.org/library/papers/42388536PubMed
42082974Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42082974PubMed
41789800Small Interfering RNA Strategies to Overcome Drug Resistance in Cancer: Pathway Targeting and Translational Advances.Eurasian J Med2026https://conductscience.org/library/papers/41789800PubMed
41779304N-benzylbenzamide derivative (SBM685) as a novel MDR1 inhibitor for overcoming 5 fluorouracil resistance in gastric cancer through computational and in vitro analysis.Discov Oncol2026https://conductscience.org/library/papers/41779304PubMed
40098719Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery.Int J Nanomedicine2025https://conductscience.org/library/papers/40098719PubMed
38616741SiRNA-mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer Cells.Curr Pharm Biotechnol2025https://conductscience.org/library/papers/38616741PubMed
38204162The landscape of nanoparticle-based siRNA delivery and therapeutic development.Mol Ther2024https://conductscience.org/library/papers/38204162PubMed
37646049Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells.Adv Pharm Bull2023https://conductscience.org/library/papers/37646049PubMed
34977908Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.Free Neuropathol2021https://conductscience.org/library/papers/34977908PubMed
34336608Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy.Bioimpacts2021https://conductscience.org/library/papers/34336608PubMed
32599901Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.Int J Mol Sci2020https://conductscience.org/library/papers/32599901PubMed
32181109The potential of micelleplexes as a therapeutic strategy for osteosarcoma disease.3 Biotech2020https://conductscience.org/library/papers/32181109PubMed
31882620Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids.Sci Rep2019https://conductscience.org/library/papers/31882620PubMed
31498151Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma.J Clin Invest2019https://conductscience.org/library/papers/31498151PubMed
31319571In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice.Cancers (Basel)2019https://conductscience.org/library/papers/31319571PubMed
31227171Review of polysaccharide particle-based functional drug delivery.Carbohydr Polym2019https://conductscience.org/library/papers/31227171PubMed
31111296Nanoparticles: Oral Delivery for Protein and Peptide Drugs.AAPS PharmSciTech2019https://conductscience.org/library/papers/31111296PubMed
30940690Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.J Pharmacol Exp Ther2019https://conductscience.org/library/papers/30940690PubMed
30609256Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1.J Cell Mol Med2019https://conductscience.org/library/papers/30609256PubMed
30108690Adaptive mechanisms of resistance to anti-neoplastic agents.Medchemcomm2017https://conductscience.org/library/papers/30108690PubMed

See all 57 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20520719

GET https://conductscience.org/api/papers/v1/20520719/references?page=2